Sep 19, 2016 Cellectar Biosciences to Present at Ladenburg Thalmann 2016 Healthcare Conference Learn More
Sep 12, 2016 Cellectar Biosciences Announces Lead Compound CLR 131 To Be Studied In Head and Neck Cancer in $12M University of Wisconsin SPORE Grant Learn More
Sep 6, 2016 Cellectar Biosciences To Present at the 18th Annual Rodman & Renshaw Global Investment Conference Learn More
Aug 12, 2016 UPDATE -- Cellectar Biosciences Announces Recent Key Accomplishments and Second Quarter 2016 Financial Results Learn More